UPDATE : Monday, September 7, 2020
상단여백
‘Risk-sharing agreements back up economic feasibility review’ by Kim Yun-mi 2019-05-22 14:46
Regulator inspecting Kolon TissuGene in US this week by Lee Hye-seon 2019-05-20 14:22
Expat students worry about hefty medical insurance fees from mid-July by Lee Han-soo 2019-05-14 14:17
State-funded smoking cessation program may face overhaul by Kwak Sung-sun 2019-05-09 15:19
‘Invossa scandal might be more far-reaching’ by Jeong Sae-im 2019-04-26 18:08
라인
Korea succeeds in reducing inflow of foreign tuberculosis patients by Lee Han-soo 2019-04-26 17:58
Korea to cooperate on healthcare with 3 Central Asian countries by Lee Han-soo 2019-04-24 17:10
‘Consider N. Korea’s adoption of health insurance in inter-Korean exchange’ by Kwak Sung-sun 2019-04-24 14:28
Regulator suspends Eutilex’ trial on cell therapy by Jeong Sae-im 2019-04-23 15:13
IVI-led consortium wins Fleming Fund's grant by Lee Han-soo 2019-04-18 11:15
라인
THAAD backlash almost over: Chinese patients to Korea up 18 % by Kwak Sung-sun 2019-04-17 16:00
HIRA generates ₩35 billion worth economic value through international biz by Song Soo-youn 2019-04-16 16:19
Anti-abortion law ruled unconstitutional in Korea by Choi Gwang-seok 2019-04-11 18:02
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests by Lee Hye-seon 2019-04-11 16:00
Regulator to probe Kolon with all possible scenarios over Invossa debacle by Lee Hye-seon 2019-04-10 15:37
라인
Korea to spend ₩480 billion for pharma, biotech sector by Kwak Sung-sun 2019-04-10 15:32
Bill supporting high-tech biopharmaceuticals blocked amid Invossa setback by Kwak Sung-sun 2019-04-05 16:15
Bodybuilders booked for smuggling anabolic steroids by Lee Hye-seon 2019-04-05 12:23
Anticipation grows for bill to support advanced biopharmaceuticals by Lee Hye-seon 2019-04-04 15:25
‘Regulator responsible for suspension of Invossa’ by Song Soo-youn 2019-04-02 15:58
여백
여백
여백
Back to Top